SCOTTS MIRACLE-GRO CO (SMG) Fundamental Analysis & Valuation

NYSE:SMG • US8101861065

Current stock price

60.96 USD
+1.31 (+2.2%)
At close:
61.0659 USD
+0.11 (+0.17%)
After Hours:

This SMG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SMG Profitability Analysis

1.1 Basic Checks

  • In the past year SMG was profitable.
  • In the past year SMG had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SMG reported negative net income in multiple years.
  • SMG had a positive operating cash flow in 4 of the past 5 years.
SMG Yearly Net Income VS EBIT VS OCF VS FCFSMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • SMG's Return On Assets of 2.96% is fine compared to the rest of the industry. SMG outperforms 71.08% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.12%, SMG belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
  • SMG had an Average Return On Invested Capital over the past 3 years of 10.89%. This is above the industry average of 6.34%.
  • The 3 year average ROIC (10.89%) for SMG is below the current ROIC(14.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.96%
ROE N/A
ROIC 14.12%
ROA(3y)-2.35%
ROA(5y)-1.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.89%
ROIC(5y)10.87%
SMG Yearly ROA, ROE, ROICSMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • SMG has a Profit Margin (2.68%) which is in line with its industry peers.
  • SMG's Profit Margin has declined in the last couple of years.
  • SMG has a Operating Margin of 13.52%. This is in the better half of the industry: SMG outperforms 72.29% of its industry peers.
  • SMG's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 31.47%, SMG is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
  • SMG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.52%
PM (TTM) 2.68%
GM 31.47%
OM growth 3Y6.65%
OM growth 5Y-2.32%
PM growth 3YN/A
PM growth 5Y-14.62%
GM growth 3Y5.81%
GM growth 5Y-1.12%
SMG Yearly Profit, Operating, Gross MarginsSMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. SMG Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SMG is still creating some value.
  • SMG has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SMG has more shares outstanding
  • Compared to 1 year ago, SMG has an improved debt to assets ratio.
SMG Yearly Shares OutstandingSMG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SMG Yearly Total Debt VS Total AssetsSMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.37 indicates that SMG is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SMG's Altman-Z score of 2.37 is fine compared to the rest of the industry. SMG outperforms 62.65% of its industry peers.
  • The Debt to FCF ratio of SMG is 7.05, which is on the high side as it means it would take SMG, 7.05 years of fcf income to pay off all of its debts.
  • SMG has a Debt to FCF ratio of 7.05. This is in the better half of the industry: SMG outperforms 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.05
Altman-Z 2.37
ROIC/WACC1.24
WACC11.36%
SMG Yearly LT Debt VS Equity VS FCFSMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that SMG should not have too much problems paying its short term obligations.
  • SMG has a Current ratio of 1.35. This is in the lower half of the industry: SMG underperforms 74.70% of its industry peers.
  • SMG has a Quick Ratio of 1.35. This is a bad value and indicates that SMG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SMG has a worse Quick ratio (0.44) than 95.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.44
SMG Yearly Current Assets VS Current LiabilitesSMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. SMG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.14% over the past year.
  • Measured over the past years, SMG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.47% on average per year.
  • The Revenue has decreased by -5.86% in the past year.
  • The Revenue has been decreasing by -3.75% on average over the past years.
EPS 1Y (TTM)37.14%
EPS 3Y-3.11%
EPS 5Y-12.47%
EPS Q2Q%13.48%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-4.54%
Revenue growth 5Y-3.75%
Sales Q2Q%-14.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.30% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.44% on average over the next years.
EPS Next Y16.57%
EPS Next 2Y15.14%
EPS Next 3Y14.09%
EPS Next 5Y14.3%
Revenue Next Year-2.87%
Revenue Next 2Y-0.2%
Revenue Next 3Y0.73%
Revenue Next 5Y2.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SMG Yearly Revenue VS EstimatesSMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
SMG Yearly EPS VS EstimatesSMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

6

4. SMG Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.88 indicates a correct valuation of SMG.
  • Based on the Price/Earnings ratio, SMG is valued a bit cheaper than the industry average as 69.88% of the companies are valued more expensively.
  • SMG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.70.
  • SMG is valuated correctly with a Price/Forward Earnings ratio of 12.36.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SMG indicates a somewhat cheap valuation: SMG is cheaper than 75.90% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. SMG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.88
Fwd PE 12.36
SMG Price Earnings VS Forward Price EarningsSMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMG is on the same level as its industry peers.
  • 89.16% of the companies in the same industry are more expensive than SMG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.86
EV/EBITDA 11.34
SMG Per share dataSMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SMG's earnings are expected to grow with 14.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y15.14%
EPS Next 3Y14.09%

5

5. SMG Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.43%, SMG is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.09, SMG pays a better dividend. On top of this SMG pays more dividend than 86.75% of the companies listed in the same industry.
  • SMG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.43%

5.2 History

  • The dividend of SMG decreases each year by -18.28%.
  • SMG has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SMG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-18.28%
Div Incr Years0
Div Non Decr Years3
SMG Yearly Dividends per shareSMG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 171.01% of the earnings are spent on dividend by SMG. This is not a sustainable payout ratio.
DP171.01%
EPS Next 2Y15.14%
EPS Next 3Y14.09%
SMG Yearly Income VS Free CF VS DividendSMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M
SMG Dividend Payout.SMG Dividend Payout, showing the Payout Ratio.SMG Dividend Payout.PayoutRetained Earnings

SMG Fundamentals: All Metrics, Ratios and Statistics

SCOTTS MIRACLE-GRO CO

NYSE:SMG (3/13/2026, 8:04:00 PM)

After market: 61.0659 +0.11 (+0.17%)

60.96

+1.31 (+2.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-28
Earnings (Next)04-29
Inst Owners76.26%
Inst Owner Change4.11%
Ins Owners0.63%
Ins Owner Change0.12%
Market Cap3.54B
Revenue(TTM)3.35B
Net Income(TTM)89.70M
Analysts81.82
Price Target74.66 (22.47%)
Short Float %7.85%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield 4.43%
Yearly Dividend2.69
Dividend Growth(5Y)-18.28%
DP171.01%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.1%
Min EPS beat(2)2.56%
Max EPS beat(2)21.65%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-0.27%
Max EPS beat(4)21.65%
EPS beat(8)6
Avg EPS beat(8)9.33%
EPS beat(12)9
Avg EPS beat(12)6.15%
EPS beat(16)12
Avg EPS beat(16)7.31%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-2.1%
Revenue beat(4)0
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)-2.1%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)5
Avg Revenue beat(16)-0.9%
PT rev (1m)1.39%
PT rev (3m)1.2%
EPS NQ rev (1m)-0.42%
EPS NQ rev (3m)-0.93%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-3.3%
Valuation
Industry RankSector Rank
PE 15.88
Fwd PE 12.36
P/S 1.06
P/FCF 9.86
P/OCF 7.92
P/B N/A
P/tB N/A
EV/EBITDA 11.34
EPS(TTM)3.84
EY6.3%
EPS(NY)4.93
Fwd EY8.09%
FCF(TTM)6.18
FCFY10.14%
OCF(TTM)7.7
OCFY12.63%
SpS57.73
BVpS-8.63
TBVpS-18.88
PEG (NY)0.96
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.96%
ROE N/A
ROCE 21.56%
ROIC 14.12%
ROICexc 14.17%
ROICexgc 19.81%
OM 13.52%
PM (TTM) 2.68%
GM 31.47%
FCFM 10.71%
ROA(3y)-2.35%
ROA(5y)-1.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.89%
ROIC(5y)10.87%
ROICexc(3y)11.14%
ROICexc(5y)11.26%
ROICexgc(3y)16.21%
ROICexgc(5y)16.69%
ROCE(3y)16.63%
ROCE(5y)16.6%
ROICexgc growth 3Y24.46%
ROICexgc growth 5Y-7.91%
ROICexc growth 3Y20.33%
ROICexc growth 5Y-2.04%
OM growth 3Y6.65%
OM growth 5Y-2.32%
PM growth 3YN/A
PM growth 5Y-14.62%
GM growth 3Y5.81%
GM growth 5Y-1.12%
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.05
Debt/EBITDA 4.27
Cap/Depr 118.26%
Cap/Sales 2.63%
Interest Coverage 3.55
Cash Conversion 84.74%
Profit Quality 400.11%
Current Ratio 1.35
Quick Ratio 0.44
Altman-Z 2.37
F-Score6
WACC11.36%
ROIC/WACC1.24
Cap/Depr(3y)111.47%
Cap/Depr(5y)111.25%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.14%
EPS 3Y-3.11%
EPS 5Y-12.47%
EPS Q2Q%13.48%
EPS Next Y16.57%
EPS Next 2Y15.14%
EPS Next 3Y14.09%
EPS Next 5Y14.3%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-4.54%
Revenue growth 5Y-3.75%
Sales Q2Q%-14.97%
Revenue Next Year-2.87%
Revenue Next 2Y-0.2%
Revenue Next 3Y0.73%
Revenue Next 5Y2.44%
EBIT growth 1Y17.36%
EBIT growth 3Y1.8%
EBIT growth 5Y-5.98%
EBIT Next Year37.3%
EBIT Next 3Y16.22%
EBIT Next 5Y12.48%
FCF growth 1Y-30.75%
FCF growth 3YN/A
FCF growth 5Y-11.17%
OCF growth 1Y-27.83%
OCF growth 3YN/A
OCF growth 5Y-7.82%

SCOTTS MIRACLE-GRO CO / SMG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SCOTTS MIRACLE-GRO CO (SMG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SMG.


What is the valuation status for SMG stock?

ChartMill assigns a valuation rating of 6 / 10 to SCOTTS MIRACLE-GRO CO (SMG). This can be considered as Fairly Valued.


Can you provide the profitability details for SCOTTS MIRACLE-GRO CO?

SCOTTS MIRACLE-GRO CO (SMG) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SCOTTS MIRACLE-GRO CO (SMG) stock?

The Price/Earnings (PE) ratio for SCOTTS MIRACLE-GRO CO (SMG) is 15.88 and the Price/Book (PB) ratio is -7.07.


Can you provide the expected EPS growth for SMG stock?

The Earnings per Share (EPS) of SCOTTS MIRACLE-GRO CO (SMG) is expected to grow by 16.57% in the next year.